Why some people get donor stem cell transplants
Part of Blood & lymphatic clinical trials.
This study looks at what factors might affect whether people who need a donor stem cell transplant actually get one. It aims to help make sure everyone has a fair chance to receive this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your doctor has recommended a donor stem cell transplant as a treatment option.
- You do not have a medical condition that makes a donor stem cell transplant unsafe or not helpful.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether getting stem cells from a younger donor works better than from an older donor for people having their first stem cell transplant to treat blood cancer.
This study looks at whether a special health evaluation designed for older adults can help doctors better plan stem cell transplants for people 55 and older with blood disorders. You would receive a series of questionnaires and tests to assess your overall health before transplant.
This study tracks patients who have had or are planning to have a stem cell transplant. It helps doctors learn more about long-term outcomes and improve care for future patients.
This study looks at how a genetic risk factor in a stem cell donor (called CHIP) may affect outcomes after an allogeneic (donor-to-recipient) stem cell transplant. It may help doctors better predict which donor factors are important for patient outcomes.
This study looks at how donating stem cells affects the health of both related and unrelated donors over time. It helps doctors better understand the long-term effects of donation.
This study compares outcomes in patients receiving stem cell transplants from either a sibling or a cousin donor. It looks at the transplant process to help doctors understand which type of donor might lead to better results for people with blood cancers.
Hear when a new Allogeneic Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.